Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Aortic Stenosis
Interventions
DRUG

Dexmedetomidine with propofol

A dexmedetomidine- dominant anesthetic will be defined as an anesthetic that included a continuous infusion of dexmedetomidine within 15 minutes of anesthesia start. This group was subsequently modified in light of retrospective data collection to specify a group receiving dexmedetomidine in combination with propofol.

DRUG

Propofol

A propofol-dominant anesthetic will be defined as an anesthetic that included a continuous infusion of propofol within 15 minutes of anesthesia start. This definition was subsequently modified to include patients who received propofol infusion but not dexmedetomidine.

All Listed Sponsors
lead

Yale University

OTHER

NCT02786264 - Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement | Biotech Hunter | Biotech Hunter